<SEC-DOCUMENT>0001193125-25-135994.txt : 20250605
<SEC-HEADER>0001193125-25-135994.hdr.sgml : 20250605
<ACCEPTANCE-DATETIME>20250605172118
ACCESSION NUMBER:		0001193125-25-135994
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250605
DATE AS OF CHANGE:		20250605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		251028204

	BUSINESS ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 720
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d15942ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROXY
STATEMENT PURSUANT TO SECTION 14(a) OF THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other
than the Registrant&#8194;&#9744; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Dynavax Technologies Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rule
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Schedule 14A filing consists of the following email distributed by Dynavax Technologies Corporation
(the &#147;Company&#148;) to its employees in connection with the Company&#146;s 2025 Annual Meeting of Stockholders. The email was first used or made available after 3:20pm ET on June&nbsp;5, 2025. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Subject: Important Reminder Ahead of June 11 Annual Meeting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Team, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Annual Meeting of Stockholders is less than one week
away on June 11. For those of you who are Dynavax stockholders and have already voted &#150; thank you! For those of you who haven&#146;t yet voted, there is still time and we encourage you to do so as soon as possible. I have pasted some
instructions below for your reference and if you have any questions, please contact our proxy solicitor, MacKenzie Partners, who can answer any questions you have at 1 (800) <FONT STYLE="white-space:nowrap">322-2885.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the last few days, three independent proxy advisory firms have issued reports and provided voting recommendations to institutional shareholders. We
received full support from two firms (ISS and Egan-Jones), which is important recognition of our team, strategy and value we are delivering to our stakeholders, and the third firm (Glass Lewis) split its recommendation. As always, thank you all for
your hard work and dedication! Let&#146;s all keep up the great work and energy we bring every day. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Instructions </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Step 1 &#150; Use the GOLD proxy card from Dynavax. </B>Deep Track&#146;s proxy materials contain a white
proxy card<B> </B>that we encourage you to disregard and NOT use to vote. If you have already voted using Deep Track&#146;s white proxy card, you have the right to change your vote and revoke your prior submitted proxy by voting using Dynavax&#146;s
gold proxy card or<B></B>&nbsp;voting instruction form (follow the instructions provided&nbsp;below). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Step 2 &#150; Cast your vote. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposal #1: </B>The Board recommends that stockholders vote &#147;FOR&#148; all four of Dynavax&#146;s
director nominees only &#150; Brent MacGregor, Scott Myers, Lauren Silvernail and Elaine Sun. You may mark &#147;FOR&#148; votes for only up to four nominees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposals #2, #3 and #4:</B> The Board recommends that stockholders vote &#147;FOR&#148; Proposals #2, #3 and
#4. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposal #5:</B> The Board recommends that stockholders vote &#147;AGAINST&#148; Proposal #5.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g15942g0605012237692.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Step 3 &#150; Submit your vote. </B>You can submit your vote using one of the following four methods, though
email, telephone or internet will be the quickest way to do so and will ensure your vote is cast on time. You only have to vote once. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>By mail</B>: Complete, sign, date and return the GOLD proxy card or voting instruction form in the
postage-paid envelope provided. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>By internet: </B>The GOLD proxy card or voting instruction form you received includes a URL to submit your
votes electronically. Then, follow the instructions on the voting website. You will be required to provide the unique control number on your proxy card or voting instruction form. If you want to vote by internet, you must submit your vote by 8:59
p.m. PT on June 10. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>By telephone: </B>Please call our proxy solicitor, MacKenzie Partners, at 1 (800) <FONT
STYLE="white-space:nowrap">322-2885.</FONT> You will be required to provide the unique control numbers on your proxy card or voting instruction form. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>By <FONT STYLE="white-space:nowrap">e-mail:</FONT> </B>If you received proxy materials via <FONT
STYLE="white-space:nowrap">e-mail,</FONT> the <FONT STYLE="white-space:nowrap">e-mail</FONT> message included a link with instructions on how to vote. You will be required to provide the unique control numbers on your proxy card or voting
instruction form. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you hold Dynavax shares in more than one account (e.g., through our employee savings plan, in registered name or
through a personal bank or brokerage account), you&#146;ll receive separate GOLD&nbsp;proxy cards or voting instruction forms for each account. To ensure all your shares are represented, please submit your vote for each account in which you hold
shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ryan </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains
&#147;forward-looking&#148; statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, which are subject to a number of risks and
uncertainties. All statements that are not historical facts are forward-looking statements. Forward-looking statements can generally be identified by the use of words such as &#147;continue,&#148; &#147;expect,&#148; &#147;will,&#148;
&#147;plan,&#148; &#147;would&#148; and similar expressions, or the negatives thereof, or they may use future dates. Forward-looking statements made in this document include statements regarding delivering value for our stockholders, our business
strategy and long-term performance. Actual results may differ materially from those set forth in this communication due to the risks and uncertainties inherent in our business, including, the risk that circumstances surrounding or leading up to our
2025 Annual Meeting may change risks related to the implementation of our long-term growth objectives, as well as other risks detailed in the &#147;Risk Factors&#148; section of our Quarterly Report on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> for the three months ended&nbsp;March 31, 2025&nbsp;and any periodic filings made thereafter, as well as discussions of potential risks, uncertainties and other important factors in our other filings with
the&nbsp;U.S. Securities and Exchange Commission. These forward-looking statements are made as of the date hereof, are qualified in their entirety by this cautionary statement and we undertake no obligation to revise or update information herein to
reflect events or circumstances in the future, even if new information becomes available. Information on&nbsp;Dynavax&#146;s&nbsp;website at <U>www.dynavax.com</U>&nbsp;is not incorporated by reference in our current periodic reports with
the&nbsp;SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Additional Information and Where to Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On&nbsp;April 17, 2025, the Company filed a definitive proxy statement on Schedule 14A (the &#147;Proxy Statement&#148;) and form of accompanying GOLD proxy
card with the&nbsp;U.S. Securities and Exchange Commission&nbsp;(the &#147;SEC&#148;) in connection with its 2025 Annual Meeting and its solicitation of proxies for the Company&#146;s director nominees and for other matters to be voted on. The
Company may also file other relevant documents with the&nbsp;SEC&nbsp;regarding its solicitation of proxies for the 2025 Annual Meeting. This communication is not a substitute for any proxy statement or other document that the Company has filed or
may file with the&nbsp;SEC&nbsp;in connection with any solicitation by the Company. STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ THE PROXY STATEMENT, ACCOMPANYING GOLD PROXY CARD AND OTHER RELEVANT DOCUMENTS FILED WITH, OR FURNISHED
TO, THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION. Stockholders may obtain a copy of the Proxy Statement, accompanying GOLD proxy card, any amendments or supplements to the Proxy Statement and any other relevant
documents filed by the Company with the&nbsp;SEC&nbsp;at no charge at the&nbsp;SEC&#146;s&nbsp;website at <U>www.sec.gov</U>. Copies will also be available at no charge at the Company&#146;s website at <U>https://</U><U><FONT
STYLE="white-space:nowrap">investors.dynavax.com/sec-filings</FONT></U>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Information Regarding Participants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is neither a solicitation of a proxy or consent nor a substitute for any proxy statement or other filings that may be made with
the&nbsp;SEC. The Company, its directors, its director nominees and certain of its executive officers and employees may be deemed to be participants in the solicitation of proxies for the 2025 Annual Meeting. Information regarding the names of such
persons and their respective direct or indirect interests in the Company, by securities holdings or otherwise, is available in the Proxy Statement, which was filed with the&nbsp;SEC&nbsp;on&nbsp;April 17, 2025, including in the sections captioned
&#147;Compensation Discussion and Analysis,&#148; &#147;Summary Compensation Table,&#148; &#147;Grants of Plan Based Awards,&#148; &#147;Outstanding Equity Awards at Fiscal Year End,&#148; &#147;Pay Ratio Disclosure,&#148; &#147;Director
Compensation,&#148; &#147;Certain Transactions,&#148; &#147;Security Ownership of Certain Beneficial Owners and Management,&#148; and &#147;Supplemental Information Regarding Participants in the Solicitation.&#148; To the extent that the
Company&#146;s directors and executive officers have acquired or disposed of securities holdings since the applicable &#147;as of&#148; date disclosed in the Proxy Statement, such transactions have been or will be reflected on Statements of Changes
in Ownership of Securities on Form 4 or Initial Statements of Beneficial Ownership of Securities on Form 3 filed with the&nbsp;SEC. These documents are or will be available free of charge at the&nbsp;SEC&#146;s&nbsp;website at <U>www.sec.gov</U>.
</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g15942g0605012237692.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g15942g0605012237692.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $B 0,# 2(  A$! Q$!_\0
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MI\#1/=RW*ELJTOW@, 8)[]*NT44 %%%% !3)8DFC,<@RIZBGT4 9%VJ'4/\
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M+?SSM!Y#,6Z],'% &C+:^3$9(;,1L0P8>=C:I(R?3.,TILE5EVV2D*59?](
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M5NBB@ J.?_5&I*9*I:,@=:!/8R&^R17ZR!0UU*?+^4Y(&,DD=N,9/TK4M_\
M5GZU7%GB8S")!*PVE\#)'IFK4*E$PW7-2D94XM,DJM>;=D8,4DC%_D$;;3G!
M[Y';-6:CGMX;F/9-&KKG.&'>J-AMH4-K'Y:,BX^ZQR1]:FIL<:11K'&H5%&
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MJ%EK%EJ%W<6UO*6E@"%U*D<,,C&>O!J_0 4444 %%%% !1110 4444 %%%%
M!1110 4A"D?, ?K2U%<0"XA,3,5!(R1CL: %\J'<?W:9SD_*.OK2B&)5"B)
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M7*,_WF63DGUH T**AM[<6^X"65PQS^\;=CBIJ "BBB@ HHHH **** "BBB@
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MR2%.W&,?*!ZF@"=9[;<Q66+=D;L,,],C/X?I2&]M 0#<PC/3,@YK&'@O1!L
M@FVH047SWPI (R.>N"1]#4MMX2T:SN!-!:E&#!L;R1G*G./JH/Y^M &V  ,
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M>\W)>NX>[7A1B!<[N.N,8Q^-5UE"R./,U,2,1D>6.,@?X9K5FL!-*\C3SKN
M 5'( J'^R048&[N68@8)D. 1T./KS0!4B+1NTD;W\FP'$9 PQ&!C^7ZTUGF
M1?,U/<3U$0P?\/QK0.FAV+-<W'52,2$= /\ #]:@6QM6<P?VA<-)GIY_((H
MJ+*[2!#)J3#>IP\8 //<XX]_I4B2.VV))=1(,N-S)C('!Y].]3O;6BAE&HLD
MH8MN,PR"  ?RXJ9]+BD=I!<3J7Y)1\9R/;K0!F_:'\O$IU-'; *[0=OZ<^M/
MBDWW$;1G4D+.N59<+C'0YZ=,UH_V:AC"O-,S*S$/N^89]Z;_ &6OELGVJZ^9
M0I;S.>#G.?6@#-BN3Y:9&H)V9(TY![9X[CG-/WR^1YGVG4=V"H7RL<XSDC%:
M(TR(2"199U8%2<2'G;C /Y4BZ9&N<3W/)+?ZT]2<_P Z ,YIP0F3J(93OPJ#
M*Y&#^'7\Z#*RK(7EU$1DE02HR.!VQ[G\JOMI,4@D\RXN7+XY,G(QZ>E TF(
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MGED\PJ;]'EB)0;  IYZ>A^7OZUMU%)<0Q,%DE1&/0$XH QQ,P&]WU0;1\R!
M>?R]J8;AD^7.JKW+>6.><]*W7ECC^_(B_P"\P'M3%N[9V*K<1,1U <<?YP:
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6BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
